Abstract Guillain-Barré Syndrome (GBS) is an acute, immune-mediated
polyradiculoneuropathy with high burden of disability and unpredictable course. Biomarkers …

Multiple sclerosis (MS) is the most common immune-mediated disease of the central
nervous system. While benign cases exist, if left untreated, MS results in the compounding …

Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central
nervous system (CNS). Symptoms of MS include focal neurological deficits such as motor …

Hypogammaglobulinämien treten bei Menschen mit Multipler Sklerose (MS) ohne
Immuntherapie in 8.1% der Patienten und unter Immuntherapie (nicht medikament …

Abbreviations: AUC ¼ area under the curve; CIS ¼ clinically isolated syndrome; EDSS ¼
expanded disability scale status; IQR ¼ interquartile range; MS ¼ multiple sclerosis; NK ¼ …

The raft of disease-modifying therapies for multiple sclerosis (mS) looks set to expand further
in light of phase III trial results presented at the european Committee for Treatment and …

Methods This study was conducted at Beth Israel Deaconess Medical Center (BIDMC), a
673-bed academic medical center in Boston, Massachusetts. At our institution, review of …

Hintergrund Geschlechtsspezifische Unterschiede bei Patienten mit MS sind bereits
untersucht worden. Dennoch ist der Einfluss des Geschlechtes auf klinische …

We read Pfuhl et al.'s article 1 with interest. Our group demonstrated that intrathecal
oligoclonal IgM bands (OCMB) were a risk factor for early conversion to MS 2 and also for …